Nasdaq Panel grants Minerva continued listing subject to equity compliance by March 31, 2025

Minerva Neurosciences, Inc.

Company must file disclosure on transactions to meet $2.5M minimum stockholders' equity by 3/31/25.
Must also provide 12-month income projections with underlying assumptions to Panel by same deadline.
Company is working toward compliance but states no assurance of regaining or maintaining listing.
Original deficiency was market value below $35M; now equity compliance is the key condition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.